The defeat of the digestive system during infection SARS-CoV-2

1. CuiJ, Li F, Shi Z L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–192

2. Woo PCY, Lau SKP, Lam CSF, et al. Discovery of seven novelmammalian and avian coronaviruses in the genus deltacoronavirussupports bat coronaviruses as the gene source of alphacoronavirusandbetacoronavirus and avian coronaviruses asthe gene source of gammacoronavirus and deltacoronavirus.JVirol. 2012;86(7):3995–4008

3. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23

4. Su S, Wong G, Shi W, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24(6):490–502

5. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–423. doi: 10.1002/jmv.25681

6. Leila Mousavizadeha, Sorayya Ghasemibc. Genotype and phenotype of COVID-19: Th eir roles in pathogenesis. Open access. https://doi.org/10.1016/j.jmii.2020.03.022 Get rights and content

7. https://biomolecula.ru/articles/kompiuternye-tekhnologii-protiv-koronavirusa-pervye-rezultaty#source-25

8. M. Hoffmann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cell (2020), doi: 10.1016/j.cell.2020.02.052

9. Y.-R. Guo, Q.-D. Cao, Z.-S. Hong, Y.-Y. Tan, S.-D. Chen, H.-J. Jin, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak– an update on the status Mil Med Res, 7 (1) (2020), pp. 1–10

10. Wrapp D., Wang N., Corbett K. S., et al. Cryo-EM structure of the 2019-nCoV Spike in the prefusion conformation. Science 2020, eabb2507

11. Lu R., Zhao X., Li J., Niu, P. et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020, 395, 565–574

12. Tang, B.; Bragazzi, N. L.; Li, Q.; Tang, S.; Xiao, Y.; Wu, J. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model 2020, 5, 248–255.

13. M. Hoff mann, H. Kleine-Weber, S. Schroeder, N. Krüger, T. Herrler, S. Erichsen, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitorCell (2020), doi: 10.1016/j.cell.2020.02.052

14. Jinyang Gu, MD; Bing Han, MD; Jian Wang, MS COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission

15. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.

16. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323:1061.

17. Jin X, Lian J-S, Hu J-H, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020. doi: 10.1136/gutjnl-2020–320926. [Epub ahead of print: 24 Mar 2020]

18. Lin L, Jiang X, Zhang Z, et al. Gastrointestinalsymptoms of 95 cases with SARS-CoV-2 infection. Gut 2020. doi:10.1136/gutjnl-2020–321013. [Epubaheadof print: 02 Apr 2020]

19. JinyangGu, MD; BingHan, MD; JianWang, MS COVID-19: Желудочно-кишечные проявления и потенциальная фекально-оральная передача. Отделение Трансплантации больницы Синьхуа, Филиал Шанхайского университета, Шанхай, Китай

20. Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020. doi:10.1053/j.gastro.2020.02.055. [Epub ahead of print: 03 Mar 2020]

21. Zhou P, Yang X–L, Wang X-G, et al. A pneumonia out-break associated with a new coronavirus of probable bat origin. Nature 2020;579:270–3.

22. Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 2020;94. doi:10.1128/JVI.00127–20. [Epub ahead of print: 17 Mar 2020].

23. Wan Y, Shang J, Sun S, et al. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol 2020;94.

24. Hashimoto T, Perlot T, Rehman A, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal infl ammation. Nature 2012;487:477–81.

25. Zhang H, Kang Z, Gong H, et al. Digestive system is a potential route of COVID-19: an analysis of singlecell coexpression pattern of key proteins in viral entry process. Gut 2020

26. Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020. doi:10.1136/gutjnl-2020–321013. [Epub ahead of print: 02 Apr 2020]

27. [Does an undiagnosed atrophic gastritis (acid-free stomach) increase the risk of coronavirus infection, its complications and mortality particularly among elderly people? [on-line] URL https://news.cision.com/biohit-oyj/r/does-an-undiagnosed-atrophic-gastritis-acid-free-stomach-increase-the-risk-of-coronavirus-infectio,c3087941 (Wed, Apr 15, 2020 09:03 CET) (https://www.is.fi/kotimaa/art-2000006465454.html?cs=email),

28. ASPI – informationagencyASPI. Coronavirus even in mild form can give a fatal complication to the liver. [On-line] URL: https://aspi.com.ua/ru/news/zdorove/koronavirus-dazhe-v-legkoy-forme-mozhet-dat-smertelnoe-oslozhnenie-na-pechen (03/16/2020)

29. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506

30. 28a. Ren Mao, Jie Liang, Jun Shen, et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Th e Lancet Gastroenterology & Hepatology, ISSN: 2468–1253, Vol: 5, Issue: 5, Page: 426–428. Doi: 10.1016/s2468–1253(20)30076–5.

31. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513

32. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506

33. Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Cholangiocyte pathobiology. Nat Rev Gastroenterol Hepatol. 2019;16(5):269–281.

34. Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profi les in the peripheral blood of SARSCoV-2 infected patients. medRxiv,2020, in press. doi: 10.1101/2020.02.16.20023671

35. Xu Z, Shi L, Wang Y et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med,2020. https://doi.org/10.1016/S2213-2600(20)30076-X

36. National Health Commission of the People’s Republic of China. Diagnosis and Treatment of Coronavirus disease 2019 (Trial Version 7). http://www.nhc.gov.cn/yzygj/s7652m/202003/a31191442e29474b98bfed5579d5af95.shtml. Accessed March 6, 2020

37. Fan Z, Chen L, Jun LI, et al. Clinical features of COVID-19-related liver damage. medRxiv. 2020; inpress. https://doi.org/10.1101/2020.02.26.20026971

38. Wenzhong Liu, Hualan Li. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. ChemRxiv. Preprint. https://doi.org/10.26434/chemrxiv.11938173.v6

39. Ferner Robin E, Aronson Jeff rey K. Chloroquine and hydroxychloroquine in covid-19 BMJ 2020; 369: m1432 doi: https://doi.org/10.1136/bmj.m1432 (Published 08 April 2020)

40. Orlova E. Petersburg scientists: The course of coronavirus depends on the level of ferritin. Network publ. “MK in St. Petersburg.” [On-line] https://spb.mk.ru/print/article/2577770 (13.04.2020)

41. Minushkin O.N., Maksimov V. A., Paltsev A. I., Saifut dinov R. G., Chernyshev A. L., Gromova R. A., Gu sa kova E. V., Radchenko V. G., Lazebnik L. B. Recommendations for the use of human placenta hydrolysate in liver diseases. Experimental and Clinical Gastroenterology. 2016;(12):75–77. (In Russ.)

42. Torshin I. Y., Gromova O. A. Worldwide experience of the therapeutic use of the human placental hydrolytes. Experimental and Clinical Gastroenterology. 2019;1(10):79–89. (In Russ.) doi: 10.31146/1682–8658-ecg-170–10–79–89

43. Boettler T, Newsome PN, Mondelli MU, Maticic M, Cordero E, CornbergM, Berg T, Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper, JHEP Reports (2020), doi: https://doi.org/10.1016/j.jhepr.2020.100113